Guardant Health ( (GH) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Guardant Health shares are sliding as investors react to sector-wide headwinds and worries over proposed 2027 U.S. federal budget cuts targeting health and diagnostic programs. The broader pressure on healthcare names is amplifying existing concerns around the company’s financial profile.
The sell-off deepened after Evercore ISI cut its price target on the stock to $90 from $110. Analysts and investors now frame the move as a “valuation reset,” spotlighting Guardant’s ongoing lack of profitability and negative cash flow outlook despite solid revenue growth.
More about Guardant Health
YTD Price Performance: -14.66%
Average Trading Volume: 1,937,037
Technical Sentiment Signal: Buy
Current Market Cap: $11.43B
For further insights into GH stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.